Novofem (Estradiol | Norethisterone Acetate, Estradiol)

Novofem combines estradiol and norethisterone acetate to act on hormonal pathways involved in estrogen and progesterone balance. It is indicated for:

• Menopausal symptom relief: reduction of hot flashes, night sweats and vaginal dryness.
• Hormone replacement therapy: prevention of bone loss and treatment of estrogen deficiency in post‑menopausal women.
• Contraception: prevention of ovulation as part of a combined oral contraceptive regimen.

• Estradiol binds to estrogen receptors (ERα and ERβ) activating genomic pathways that restore estrogenic effects on target tissues, while norethisterone acetate binds to progesterone receptors, providing progestogenic activity that opposes estrogen‑driven endometrial proliferation and contributes to contraceptive efficacy. The combined action modulates the hypothalamic‑pituitary‑gonadal axis, suppressing ovulation and alleviating estrogen‑deficiency symptoms.

Novofem may cause a range of adverse reactions.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Breast tenderness: discomfort or swelling of breast tissue.
• Headache: transient cranial pain.
• Weight gain: fluid retention or increased appetite.
• Mood changes: irritability or mild depression.
• Irregular bleeding: spotting or breakthrough bleeding.

Serious or Rare Side Effects

• Thromboembolic events: deep vein thrombosis or pulmonary embolism.
• Stroke or transient ischemic attack.
• Myocardial infarction: heart attack risk, especially in smokers.
• Hepatic adenoma: benign liver tumor.
• Severe allergic reaction: anaphylaxis, angioedema.
• Visual disturbances: sudden loss of vision or eye pain.

Novofem should be used with awareness of several safety considerations.

• Assess cardiovascular risk: evaluate history of clotting disorders before prescribing.
• Review smoking status: avoid use in women over 35 who smoke.
• Monitor liver function: caution in patients with hepatic impairment.
• Consider bone health: assess osteoporosis risk in long‑term users.
• Evaluate hormone‑sensitive conditions: avoid in active breast or endometrial cancer.
• Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Novofem can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce hormonal levels and contraceptive efficacy.
• Anticoagulants (e.g., warfarin): increased risk of bleeding.
• Selective serotonin reuptake inhibitors (e.g., fluoxetine): may elevate plasma estrogen levels.

Moderate Interactions (Monitor Closely)

• Antibiotics (e.g., tetracycline): may slightly decrease contraceptive reliability.
• Antifungals (e.g., ketoconazole): can increase hormone concentrations.
• Antiepileptics (e.g., phenytoin): may lower hormone effectiveness.
• Herbal supplements (e.g., St. John’s wort): potential reduction in drug exposure.